Overview
Dr. Eduardo Blanco Calvo, Established At The Laboratory Of Experimental Neuropsychopharmacology[…] Jobs in Málaga, Andalusia, Spain at Universidad de Málaga
Title: Dr. Eduardo Blanco Calvo, Established At The Laboratory Of Experimental Neuropsychopharmacology[…]
Company: Universidad de Málaga
Location: Málaga, Andalusia, Spain
Laboratory of Experimental Neuropsyhopharmacology
Organisation / Company UNIVERSIDAD DE MÁLAGA Department Psychobiology Laboratory Laboratory of Experimental Neuropsyhopharmacology Is the Hosting related to staff position within a Research Infrastructure?
No
Dr. Eduardo Blanco Calvo is a Tenured Associate Professor in Psychobiology at the University of Málaga (UMA), with over 15 years of experience in preclinical research on drug addiction and neuropharmacology.
He leads the Laboratory of Experimental Dr. Eduardo Blanco Calvo is a tenured Associate Professor in Psychobiology at the University of Málaga, with more than 20 years of experience in preclinical research on drug addiction and neuropharmacology.
He works in the Laboratory of Experimental Neuropsychopharmacology (Faculty of Psychology), focused on understanding the neurobiological substrates of addictive behaviours and the long-term impact of drug exposure on brain function and behaviour.
The research group combines behavioural neuroscience, pharmacological interventions, and animal models of substance use disorders (cocaine and alcohol) to explore vulnerability and resilience mechanisms, with a growing interest in the intersection with neurodegenerative diseases such as Parkinson's disease.
The laboratory has a solid track record of publications in high-impact journals, participation in national and international projects, and established collaborations with leading researchers in neuropsychopharmacology.
The team offers a dynamic and supportive research environment, state-of-the-art facilities for behavioural testing and neurochemical analysis, and access to UMA's doctoral and postdoctoral training resources.
Research topic(s)
The Selected MSCA PF Candidate Will Be Invited To Develop a Proposal Aligned With One Or More Of The Following Areas
Neuropharmacological mechanisms of addiction
, with a focus on psychostimulants (e.g., cocaine) and depressants (e.g., alcohol).
Long-term behavioural and neurochemical consequences of drug exposure
, including compulsive drug-seeking, relapse, and cognitive impairment.
Interactions between addiction and neurodegenerative diseases
, such as Parkinson's disease, exploring common dopaminergic dysregulation and vulnerability pathways.
Development of novel preclinical models and pharmacological strategies
for prevention and treatment of addictive behaviours.
We are particularly interested in candidates with a background in
behavioural neuroscience, neuropsychopharmacology, or related biomedical fields
, Who Have Experience With
rodent models, stereotaxic surgery, neurochemical techniques (IHC, WB, rt-q-PCR, ELISA) and chemogenetic techniques (DREADDs)
, or
computational analysis of behavioural data
The fellow will benefit from strong mentorship, interdisciplinary collaborations, and opportunities to participate in teaching, grant writing, and career development activities at UMA.
Expressions of interest
We invite interested candidates to send the following documents to
by
June 15th, ****
:
A
one-page expression of interest
outlining your research background, alignment with the proposed topics, and initial ideas for a possible MSCA PF project.
A
detailed CV
, including publication list and relevant research experience.
Candidates must fulfil the
MSCA PF **** eligibility criteria
, including mobility rules and PhD completion requirements.
Only shortlisted candidates will be contacted for further development of the application.
If applicable, feel free to include a brief statement of motivation or questions about specific aspects of the hosting offer.
#J-*****-Ljbffr
